Performance
5 Days
-8.80%
1 Month
-28.77%
3 Months
-19.89%
6 Months
27.12%
1 Year
93.68%
2 Year
33.84%
Key data
Stock price
$11.64
DAY RANGE
$11.64 - $13.37
52 WEEK RANGE
$6.64 - $35.52
52 WEEK CHANGE
$0.58
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Shai Yarkoni
Region: US
Website: cellect.co
Employees: 2,020
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NASDAQ
Industry:
Sector:
Region: US
Website: cellect.co
Employees: 2,020
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NASDAQ
Industry:
Sector:
Cellect Biotechnology has developed a breakthrough technology, for the selection of stem cells from any given tissue, that aims to improve a variety of stem cell-based therapies.
Recent news